Results 141 to 150 of about 36,401 (249)

Rhinocerebral Mucormycosis in a Patient with AIDS: A Complication of Diabetic Ketoacidosis Following Pentamidine Therapy [PDF]

open access: bronze, 1996
Vicente Abril   +5 more
openalex   +1 more source

DEKODE—A cloud‐based performance feedback model improved DKA care across multiple hospitals in the UK

open access: yesDiabetic Medicine, Volume 42, Issue 6, June 2025.
Abstract Aim A current gap in Diabetes‐related ketoacidosis (DKA) research is understanding the factors contributing to variations in care and outcomes between people admitted with DKA. We aimed to create a system to facilitate gathering data on DKA management across multiple centres and identify trends in complications and outcomes associated with DKA.
Lakshmi N. Rengarajan   +32 more
wiley   +1 more source

Guidelines for the management of diabetes‐related ketoacidosis (DKA) have been poorly adopted and implemented, resulting in a lack of improvement in outcomes

open access: yesDiabetic Medicine, Volume 42, Issue 6, June 2025.
Abstract Aims The Joint British Diabetes Society‐Inpatient (JBDS‐IP) group recommends reducing fixed rate intravenous insulin infusion (FRIII) from 0.1 to 0.05 units/kg/h when blood glucose falls <14 mmol/L to reduce the risk of complications associated with acute management of diabetes‐related ketoacidosis. However, whether this change results in real‐
Angelica Sharma   +35 more
wiley   +1 more source

Diabetic Ketoacidosis-Associated Brain Injury: A Rare but Serious Complication. [PDF]

open access: yesJCEM Case Rep
Bencharfa B   +5 more
europepmc   +1 more source

A CASE OF DIABETIC KETOACIDOSIS WITH A MARKEDLY INCREASED LEVEL OF SERUM CREATINE PHOSPHOKINASE (CPK) AND MYOGLOBIN

open access: bronze, 1982
Shinobu Tanabashi   +5 more
openalex   +2 more sources

Managing discordance between HbA1c and glucose management indicator

open access: yesDiabetic Medicine, Volume 42, Issue 6, June 2025.
Abstract Aims The assessment of haemoglobin A1c (HbA1c) continues to play an essential role in diabetes care; however, major advances in new technologies widen the armament available to clinicians to further refine treatment for their patients. Whilst HbA1c remains a critical glycaemic marker, advances in technologies such as Continuous Glucose ...
Erna Lenters‐Westra   +6 more
wiley   +1 more source

Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 2909-2919, June 2025.
Abstract Automated insulin delivery (AID) systems, which consist of an insulin pump, a continuous glucose monitoring system and a software algorithm to automate insulin delivery based on real time glycaemic data, are rapidly evolving. AID is now strongly recommended as the insulin delivery method of choice for people with type 1 diabetes.
Cari Berget   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy